TL;DR
Get workout gear delivered free — and shop member deals
- Fast, free delivery on millions of items
- Access to Prime Big Deal Days deals on October 6–7
- Prime Video, Amazon Music and more included
Researchers report that imidazole propionate (ImP), a molecule made by some gut bacteria, was associated with Alzheimer’s-related biological markers and faster cognitive decline in a study of nearly 1,200 people. Mouse experiments also linked ImP exposure to abnormal amyloid and tau accumulation, but the findings do not establish that ImP causes Alzheimer’s or that lowering it prevents dementia.
Researchers report that imidazole propionate (ImP), a molecule produced by some gut bacteria, may be connected to Alzheimer’s-related changes in the brain and faster cognitive decline. In a study published in Nature Communications, mouse experiments and blood-sample data from nearly 1,200 people pointed to ImP as a possible research target, but the human findings show an association rather than proof that the molecule causes dementia.
The team, led by University of Wisconsin-Madison researchers Barbara Bendlin and Federico Rey, examined ImP, which certain intestinal bacteria produce while using histidine, an amino acid. The amount produced varies among people. Researchers say bacteria capable of making ImP are present in many people but are generally not abundant; the molecule can pass from the gut into the bloodstream and reach other parts of the body.
In mice, the researchers found that ImP reaching the brain increased the accumulation of abnormal beta amyloid and tau proteins, which are associated with Alzheimer’s disease. The team also analyzed blood samples from nearly 1,200 participants in the Wisconsin Registry for Alzheimer’s Prevention and studies run through the Wisconsin Alzheimer’s Disease Research Center. Higher blood ImP levels were associated with biological markers linked to abnormal proteins and impaired neuron function, as well as faster decline on cognitive tests over time.
The researchers also identified a genetic variation associated with substantially higher ImP concentrations in blood. About 43% of participants carried the variation. The team suspects it could affect how efficiently the kidneys remove ImP, but that explanation remains a hypothesis. The study’s authors include researchers from the University of California, Los Angeles, and the University of Gothenburg, and the work received support from U.S. research agencies and the Wisconsin Partnership Program.
A New Lead in Alzheimer’s Research
The results add a possible link between gut bacteria and brain health to an area researchers have been investigating for years. If further work confirms that ImP contributes to disease processes, the molecule or the way it enters and persists in the bloodstream could offer a more specific target for prevention research than broad attempts to change the gut microbiome.
That possibility matters because the study connects a measurable blood molecule with both biological markers and changes in thinking and memory. Still, it is too early to treat ImP as a proven cause, a diagnostic test, or a treatment target with established clinical benefit. The research does not show that lowering ImP would prevent Alzheimer’s or slow decline in people who already have dementia.
gut health supplements for cognitive support
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
From Gut Microbes to Blood ImP
The Wisconsin team had previously reported differences in the intestinal microbial communities of people with Alzheimer’s and healthy individuals. The current study follows that line of research by examining a particular bacterial product rather than treating the microbiome as a single factor. ImP had already been linked in earlier research to type 2 diabetes and coronary artery disease; the new report examines possible associations with brain changes.
ImP is generated as gut bacteria process histidine, an amino acid people need and obtain from foods, including protein-rich foods. Bendlin cautioned that this makes a simple dietary restriction an unlikely answer: histidine is present in many foods and is essential to human health. The researchers instead raised the prospect of treatments that could selectively lower ImP in the blood, if future evidence supports that approach.
“Since then, we’ve been trying to figure out how this difference in the gut perhaps leads to changes in the brain.”
— Barbara Bendlin, University of Wisconsin-Madison professor of medicine
As an affiliate, we earn on qualifying purchases.
Cause and Treatment Remain Unproven
The human results are observational: they show that higher ImP levels occurred alongside Alzheimer’s-related markers and faster cognitive decline, but they cannot establish that ImP caused either outcome. The mouse findings provide experimental evidence of effects in that model, but do not demonstrate the same causal effect in people. The report does not establish whether ImP rises before disease-related changes, contributes to them, or is influenced by other factors.
The proposed kidney explanation for the genetic association also needs testing. It is not yet clear whether lowering ImP in people would change their risk or cognitive trajectory, which groups might benefit, or how such a reduction could be achieved safely. No ImP-lowering treatment was tested, and the researchers say dietary changes alone may not be a straightforward way to reduce the molecule.
blood test for Alzheimer’s risk markers
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Testing ImP as a Treatment Target
Further studies will need to test whether ImP directly contributes to disease processes in people and clarify how the identified genetic variation affects blood levels. Researchers would also need to develop and evaluate a method for reducing ImP before claiming that doing so can prevent Alzheimer’s or slow cognitive decline. For now, the study offers a research direction, not a clinical recommendation: readers should not remove histidine-containing foods or change treatment based on these findings.
supplements to support gut-brain axis
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
What is imidazole propionate?
Imidazole propionate (ImP) is a molecule made by some gut bacteria as they process histidine, an amino acid essential to human health. It can enter the bloodstream after being produced in the gut.
Does the study prove ImP causes Alzheimer’s disease?
No. The human data show an association between higher blood ImP and Alzheimer’s-related markers and faster cognitive decline. Mouse experiments found effects on amyloid and tau accumulation, but neither result proves that ImP causes Alzheimer’s in people.
Should people avoid foods that contain histidine?
The researchers did not recommend avoiding particular foods. Histidine is essential and occurs in many foods, and the report says reducing ImP through diet may not be simple. The study does not provide a dietary treatment plan.
Could lowering ImP prevent or slow dementia?
That is a possibility researchers want to investigate, not an established benefit. The study did not test an ImP-lowering drug or show that reducing the molecule changes Alzheimer’s risk or cognitive decline in people.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
